Location: Eric P. Newman Educational Center (EPNEC) at Washington University School of Medicine
Theme: Methods in Patient Centered Outcomes Research (PCOR) and Comparative Effectiveness Research (CER)
Jerry Krishnan, MD, PhD, University of Illinois at Chicago
Richard Platt, MD, MSc, Harvard Pilgrim Health Care Institute
Consuelo Wilkins, MD, MSCI, Vanderbilt-Meharry Alliance, Vanderbilt Institute for Clinical and Translational Sciences
Soko Setoguchi-Iwata, MD, DrPH, Duke Clinical Research Institute, University of North Carolina at Chapel Hill
Kaharu Sumino, MD, MPH, Washington University School of Medicine
Tanya Wildes, MD, Washington University School of Medicine
Timothy McBride, PhD, Washington University
Wil Franklin, MS, LPC, Integrated Health Network
Steven Kymes, PhD, CVS Caremark Corporation
Registration for this event is required.
Agenda: Agenda now Available HERE!
What is Stakeholder-Centered Research? - Jerry Krishnan, MD, PhD
Community/Academic Partnerships in Comparative Effectiveness Research: Keeping it Patient-Centered - Wil Franklin, MS, LPC
Experience from PCORI Asthma Study-How are we Engaging Stakeholders in the Community? - Kaharu Sumino, MD, MPH
The Evolving Common Electronic Data Platform for FDA, PCORI, and NIH - Richard Platt, MD, MSc
The Limitations of 'Big Data' in Improving Patient Reported Outcomes - Steven Kymes, PhD
Presentation and Breakout Discussions to Include:
"Innovative CER Methods, Including Stakeholder Engagement"
"Leveraging Electronic Resources and Health IT to Build a CER Infrastructure"
"CER & Rural Populations"
"Implementing CER Findings in Safety Net Clinics"
"CER & Older Populations"
Poster presentations will take place during the registration and breakfast time in the Main Lobby of EPNEC.
Mary C. Politi, PhD, Victoria F. Fraser, MD, Graham A. Colditz, MD, DrPH
This live activity is being sponsored by Washington University School of Medicine, Continuing Medical Education.
Washington University is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
Washington University designates this live activity for a maximum of 5.25 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
All speakers, planning committee members, or persons in a position to influence the content of an educational activity, are expected to disclose to the audience any financial interest or other relationship (1) with the manufacturer(s) of any commercial product(s) and/or provider(s) of commercial services discussed in an educational presentation and (2) with any commercial supporters of the educational activity. Funding and other fiscal relationships with non-profit or government organizations and with non-healthcare-related companies do not have to be disclosed. All presenters’ disclosures were reported and are indicated with their presentations. Presenters are also expected to openly disclose inclusion of discussion of any off-label, experimental, or investigational use of drugs or devices in their presentations. Presentations are expected to be based on evidence that is accepted within the profession of medicine as adequate justification for their indication in the care of patients. All scientific research should conform to the generally accepted standards of experimental design, data collection and analysis. These presentations are the views and experiences of the presenters. The presenters’ views do not represent the policy or position of Washington University School of Medicine. Washington University School of Medicine, Continuing Medical Education is the sponsor for CME credits.
This program is supported by Washington University in St. Louis School of Medicine and the Clinical and Translational Science Award (CTSA) program of the National Center for Advancing Translational Sciences, Grant Number UL1 TR000448.
Contact Rachel Lamp for more information.